Full name
PHARMACY SOLUTIONS SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
uses securityreCAPTCHA
70.22.Z - Head office activities and management consultancy
46.18.Z - Activity of agents involved in wholesale trade of other specified goods
46.46.Z - Wholesale trade of pharmaceutical and medical products
47.29.Z - Retail trade
47.73.Z - Retail sale of pharmaceutical products
47.74.Z - Retail sale of medical and orthopedic products
47.75.Z - Retail sale of cosmetics and toiletries
47.91.Z - Intermediary retail sale, non-specialized
73.1 - Advertising
82.99.Z - Other business support activities, not elsewhere classified
2021 | 2022 | 2023 | ||
---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Profit (loss) on sale | 1,1 | 0,7 | 1,8 | 169,2 |
Gross profit (loss) | 1,2 | 0,9 | 1,6 | 77,8 |
EBITDA | 1 | 0,5 | 1,4 | 176,3 |
Short time liabilities | 1,7 | 3,2 | 4,3 | 34,9 |
Other operating costs | 0,4 | 0,3 | 0,5 | 82,4 |
Equity capital | 1,8 | 1,4 | 2 | 46,5 |
Operating profit (EBIT) | 1 | 0,5 | 1,4 | 189,4 |
Assets | 4,1 | 4,8 | 6,8 | 42 |
Net profit (loss) | 1 | 0,9 | 1,3 | 50,7 |
Cash | 0,4 | 0 | 0 | 82,1 |
Net income from sale | 9,5 | 10,6 | 14,8 | 38,7 |
Liabilities and provisions for liabilities | 2,3 | 3,4 | 4,7 | 40,1 |
Working assets | 3,2 | 4,3 | 5,8 | 34,7 |
Other income costs | 0,3 | 0,1 | 0 | -34,3 |
Depreciation | 0 | 0 | 0 | -26,9 |
% | % | % | p.p. | |
Profitability of capital | 54,9 | 63 | 64,8 | 1,8 |
Equity capital to total assets | 43,4 | 28,8 | 29,8 | 1 |
Gross profit margin | 12,6 | 8,7 | 11,1 | 2,4 |
EBITDA Margin | 10,4 | 4,8 | 9,5 | 4,7 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 67 | 109 | 106 | -3 |
Current financial liquidity indicator | 1.8555562496185303 | 1.350600004196167 | 1.3486285209655762 | -0,1 |
Net dept to EBITDA | 2,9 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane